Back to state act
Description
On 14 December 2021, Malaysia’s National Pharmaceutical Regulatory Agency approved a clinical trial import license to import Molnupiravir for Merck Sharpe & Dohme (Malaysia) Sdn and Patheon Pharma...
Sign in or create a free account to see full description
Intervention Details
Intervention Type
Import licensing requirement
MAST Chapter
E: Non-automatic licensing, quotas etc.
Implementation date
14 Dec 2021
Revocation date
14 Sep 2022
Implementation level
National
Affected flow
Inward
Announced as temporary
Yes
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 2 products
Threads
See all
Liberalising Trade Policy Measures
This Thread tracks liberalising trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
14451
interventions
186
jurisdictions